Ibogaminalog

Ibogaminalog
Clinical data
Other names	DM-506
Identifiers
	IUPAC name 3-methyl-2,4,5,6-tetrahydro-1H-azepino[4,5-b]indole;
CAS Number	7546-66-9 ;
PubChem CID	24183;
ChemSpider	22605;
CompTox Dashboard (EPA)	DTXSID70226391 ;
Chemical and physical data
Formula	C13H16N2
Molar mass	200.285 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCC2=C(CC1)NC3=CC=CC=C23;
	InChI InChI=1S/C13H16N2/c1-15-8-6-11-10-4-2-3-5-12(10)14-13(11)7-9-15/h2-5,14H,6-9H2,1H3; Key:WBCPONKOWIDTJM-UHFFFAOYSA-N;

Ibogaminalog (developmental code name DM-506) is a drug of the ibogalog group first invented in the 1960s, which acts as both a partial agonist at the 5-HT_2A receptor, and a negative allosteric modulator at the α7 and α9α10 nicotinic acetylcholine receptors. It can be regarded as a structurally simplified derivative of ibogaine and has been researched both for anti-addictive effects and for the treatment of neuropathic pain.